No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Wednesday, October 22, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Stock Market

Hong Kong’s Regencell Bioscience triples in latest surge for a speculative stock

by TheAdviserMagazine
4 months ago
in Stock Market
Reading Time: 4 mins read
A A
Hong Kong’s Regencell Bioscience triples in latest surge for a speculative stock
Share on FacebookShare on TwitterShare on LInkedIn


Hong Kong Skyline

Nikada | E+ | Getty Images

Regencell Bioscience Holdings, an early-stage, Hong Kong-based bioscience company with no revenue, is the latest speculative overseas stock to attract an unusual surge in trading demand.

Shares of Regencell, which says it develops traditional Chinese herb treatments to treat childhood attention deficit hyperactivity disorder and autism, more than tripled on Monday — soaring more than 280% by the close. A 38-for-1 split declared on June 2 took effect on Monday.

The company’s year to date performance is off the charts too, having risen 46,000% in 2025. By Monday’s close, Regencell, founded in 2014 and traded on Nasdaq under the ticker ‘RGC’ since 2021, had a total market capitalization of $29.7 billion, according to S&P Capital IQ.

Regencell CEO Yat-Gai Au controls 86.24% of the total number of shares outstanding, according to FactSet data.

Stock Chart IconStock chart icon

Regencell Bioscience Holdings in 2025.

Regencell is the latest example of a speculative international stock attracting attention during summer trading. In August, 2022, for example, AMTD Digital, a Hong Kong-based fintech company, climbed 126%, briefly giving it a market value greater than Coca-Cola and Bank of America.

Regencell’s market value is now about equal with Nasdaq-traded Lululemon and tops Super Micro Computer and Fifth Third Bancorp.

Earlier this month, Regencell explained the stock split as designed solely “to enhance liquidity in the market for the company’s ordinary shares and make the shares more accessible to investors.” Stock splits do not change anything fundamentally about a company.

Regencell’s surge also came amid an increased focus on alternative medicines after Robert F. Kennedy Jr. was sworn in as Secretary of the U.S. Department of Health and Human Services in February. Kennedy, a vaccine skeptic, has taken steps to discourage routine immunizations in the U.S., last week removing all of the members of a panel that advises the Centers for Disease Control and Prevention on vaccines.

Regencell’s stock often makes huge one-day swings. For example, shares jumped roughly 30% on March 21, before dropping 30% the following trading day.

Obscure treatments, zero revenue

In spite of the wild spike in the stock, little is known about the efficacy and commercialization of the Regencell’s treatments for ADHD and Autistic Spectrum Disorders.

Regencell’s business centers on a proprietary Traditional Chinese Medicine formula (TCM) developed in a partnership with TCM practitioner Sik-Kee Au using his “Sik-Kee Au TCM Brain Theory.” Sik-Kee Au is the father of the Regencell chief executive officer Yat-Gai Au, the company said in a 2022 statement.

Three liquid-based, orally TCM formulae candidates claim to address mild, moderate and severe conditions and only contain natural ingredients such as so-called “detoxication herbs,” blood circulation herbs and digestion herbs.

“These TCM formulae form the basis of our TCM product candidates, which we intend to develop and commercialize for the treatment of ADHD and ASD,” Regencell’s website reads.

In its latest annual report filed last October, Regencell said that it had not generated any revenue, nor filed for any regulatory approvals of its TCM formulas. For the fiscal years ended June 2024 and 2023, Regencell incurred total net losses of $4.36 million and $6.06 million, respectively, according to a 20F filing to the SEC.

“We have not generated revenue from any TCM formulae candidates or applied for any regulatory approvals, nor have distribution capabilities or experience or any granted patents or pending patent applications and may never be profitable,” read the filing.

Regencell has not responded to a CNBC request for comment.

Regencell’s latest patient case study, dated Nov. 15, 2023, said 28 patients were given the treatment over a period of three months in a second efficacy trial and showed an improvement in symptoms of ADHD and ASD, according to the company’s webpage.

In an earlier case, Regencell said in a 2021 news release that it treated a dozen patients with suspected or confirmed Covid-19 cases, using a modified version of Au’s modified proprietary cold and flu TCM formula. What was described as an improvement of Covid conditions led Regencell to form a joint venture with Honor Epic Enterprises Limited in Sept. 2021 to conduct further tests and commercialize the company’s Covid treatment in ASEAN countries, according to the statement.

Online buzz

The stock has attracted little chatter on social media over the past few years. Those comments that have been made suggest both retail trader enthusiasm — and skepticism.

One user on the Reddit page “r/Shortsqueeze” wrote on Monday that Regencell is “trading like a meme coin. Bought a little to see what happens and it dropped 50% right after lol.” Another user said in a post made three months ago, “I scalp RGC everyday for a bit of profit.” The stock jumped 1,360% in May alone.

On LinkedIn in May, one investor said he “can’t stop laughing,” after reading the company description. Another post from a user in the pharmaceutical industry, according to his profile, last week said Regencell has become the “stock to watch” after its spike in May on “no official news or catalysts.” Another LinkedIn user last month commented on Regencell, saying, “China based, low volume and no official news, bizarro.”

On X, one user wrote in a Monday post said, “for #CompleteBullsh__CompanyOfTheYear I nominate regencell.”

— CNBC’s Scott Schnipper contributed reporting.



Source link

Tags: BioscienceHongKongslatestRegencellspeculativestocksurgeTriples
ShareTweetShare
Previous Post

Wefox wraps up sale of Italian operations to J.C. Flowers

Next Post

Bitcoin User Accidentally Sent $60,000 in Fees—Don’t Make the Same Mistake

Related Posts

edit post
How to Turn Your Bucket List Into an Investment Plan

How to Turn Your Bucket List Into an Investment Plan

by TheAdviserMagazine
October 21, 2025
0

Bucket list dreams aren’t just for someday—they can shape how you invest today. We all carry dreams: dancing at a...

edit post
One-time penny stock Beyond Meat soars after addition to meme ETF, jumps 47% on Tuesday

One-time penny stock Beyond Meat soars after addition to meme ETF, jumps 47% on Tuesday

by TheAdviserMagazine
October 21, 2025
0

In this photo illustration, Beyond Meat's Beyond Burgers are shown on February 29, 2024 in Chicago, Illinois.Scott Olson | Getty...

edit post
There’s No Hiding from Holiday Returns and Overstock

There’s No Hiding from Holiday Returns and Overstock

by TheAdviserMagazine
October 16, 2025
0

The holiday rush doesn’t end at checkout; in fact, it’s just the beginning for retailers and brands bracing for the...

edit post
Financial Feminism 101: Why Every Woman Should Talk Investing

Financial Feminism 101: Why Every Woman Should Talk Investing

by TheAdviserMagazine
October 15, 2025
0

Let’s be honest — investing talk still feels like a man’s world. Suits, charts, golf, and jargon that make finance...

edit post
B-Stock Partners with Balance to Power Flexible Payments and Terms on its B2B Recommerce Platform

B-Stock Partners with Balance to Power Flexible Payments and Terms on its B2B Recommerce Platform

by TheAdviserMagazine
October 14, 2025
0

The integration increases buyers’ purchasing power, accelerates fulfillment, and boosts operational efficiency New York, NY – October 14, 2025 –...

edit post
Getting Started: How to Register

Getting Started: How to Register

by TheAdviserMagazine
October 10, 2025
0

Ready to join the world’s largest B2B platform for returned and excess inventory? Consider this your quick start guide to...

Next Post
edit post
Bitcoin User Accidentally Sent ,000 in Fees—Don’t Make the Same Mistake

Bitcoin User Accidentally Sent $60,000 in Fees—Don’t Make the Same Mistake

edit post
Sequoia-backed Crosby launches a new kind of AI-powered law firm

Sequoia-backed Crosby launches a new kind of AI-powered law firm

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

October 9, 2025
edit post
Barclays Q3 earnings

Barclays Q3 earnings

0
edit post
The U.S. government shutdown means investors are flying blind when it comes to high-quality data—and they like it that way

The U.S. government shutdown means investors are flying blind when it comes to high-quality data—and they like it that way

0
edit post
Profits are Social Authentication – Econlib

Profits are Social Authentication – Econlib

0
edit post
Dogecoin Bullish Fractal Suggests 800% Surge Is Coming Amid Momentum Acceleration

Dogecoin Bullish Fractal Suggests 800% Surge Is Coming Amid Momentum Acceleration

0
edit post
5 Home Equity Line Pitfalls Seniors in California Didn’t Expect

5 Home Equity Line Pitfalls Seniors in California Didn’t Expect

0
edit post
Free Banjo Robinson Children’s Educational Activity Subscription Pack {Just Pay  shipping!}

Free Banjo Robinson Children’s Educational Activity Subscription Pack {Just Pay $2 shipping!}

0
edit post
The U.S. government shutdown means investors are flying blind when it comes to high-quality data—and they like it that way

The U.S. government shutdown means investors are flying blind when it comes to high-quality data—and they like it that way

October 22, 2025
edit post
Profits are Social Authentication – Econlib

Profits are Social Authentication – Econlib

October 22, 2025
edit post
Dogecoin Bullish Fractal Suggests 800% Surge Is Coming Amid Momentum Acceleration

Dogecoin Bullish Fractal Suggests 800% Surge Is Coming Amid Momentum Acceleration

October 22, 2025
edit post
Free Banjo Robinson Children’s Educational Activity Subscription Pack {Just Pay  shipping!}

Free Banjo Robinson Children’s Educational Activity Subscription Pack {Just Pay $2 shipping!}

October 22, 2025
edit post
Barclays Q3 earnings

Barclays Q3 earnings

October 22, 2025
edit post
Germany to buy Rafael Spike missiles for €2b

Germany to buy Rafael Spike missiles for €2b

October 22, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • The U.S. government shutdown means investors are flying blind when it comes to high-quality data—and they like it that way
  • Profits are Social Authentication – Econlib
  • Dogecoin Bullish Fractal Suggests 800% Surge Is Coming Amid Momentum Acceleration
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.